干细胞治疗肺动脉高压的进展

Progress of Stem Cell Treatment of Pulmonary Arterial Hypertension

肺动脉高压(pulmonary arterial hypertension,PAH)是一种严重威胁人类健康的难治性疾病。其手术治疗效果不佳。临床多以药物治疗为主,达到缓解症状、改善生活质量、预防疾病进展的目的。近年来,干细胞的研究为肺动脉高压的治疗提供了新的方向。研究证实其治疗效果可优于传统方法。随着研究的深入,干细胞治疗正越来越受到大家的关注。本文就干细胞治疗肺动脉高压应用的进展进行综述。

Pulmonary arterial hypertension is a kind of intractable disease which threatens human health severely. The results of operation are unsatisfactory. Clinical drug therapy is the major treatment which aims to relieve symptoms, improve the quality of life, and prevent the disease from progressing. Over the last several years, the studies of stem cells provide a new direction for the treatment of pulmonary arterial hypertension. It＇s demonstrated that the therapeutic effects of stem cells are better than that of the traditional methods. With the deepening of the researches, the therapy of stem cells is more and more compelling. The therapy of stem cells for pulmonary arterial hypertension is reviewed in this paper.